Delivery Order SPE2DB22D2211-SPE2DB25FRQQF

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,727.79 and is for the delivery of 4566872730 CLOBAZAM 10 MG TABLET 100S. The contract is a Firm Fixed Price arrangement with a period of performance through January 9, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565532789 - CLOBAZAM 10 MG TABLET 100S. The award has a firm fixed price of $6,296.78 and an ultimate completion date of August 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the DLA to...
This federal contract award, valued at $4,135.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, with a period of performance ending on February 5, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $1,555.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, a prescription medication, with a completion date of November 5, 2024. The contract is structured as a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,302.58 firm fixed-price delivery order is for the supply of 4566848238 - CLOBAZAM 10 MG TABLET 100S, with a completion date of January 7, 2025. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,253.85 firm-fixed-price delivery order is for the supply of 4566343407 - CLOBAZAM 10 MG TABLET 100S, with a completion date of November 6, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,309.74 Firm Fixed Price Delivery Order contract is for the supply of 4566401651 - CLOBAZAM 10 MG TABLET 100S, with a period of performance through November 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves...
This federal contract award with ID SPE2DB20D1100|SPE2DB25FA2Y6 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,166.60 firm fixed-price delivery order contract is for the delivery of 4567072342 CLOBAZAM 10 MG TABLET 100S, with a performance period through January 29, 2025. The contract is not designated with any set-aside requirements, indicating open competition....
This federal contract award, with an ID of SPE2DB22D3501|SPE2DB25FUK63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,555.93 Firm Fixed Price Delivery Order contract is for the delivery of 4567140962 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm-fixed-price delivery order, valued at $2,042.53, is for the supply of CLOBAZAM 10 MG TABLET 100S. This award is not associated with a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRQQF
    Delivery Order

This is a delivery order (SPE2DB25FRQQF) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,591.87 firm fixed-price contract is for the delivery of 4567174923 - CLOBAZAM 10 MG TABLET 100S, with a period of performance through February 6, 2025.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that larger IDC contract, enabling efficient government procurement of essential pharmaceutical commodities.

The contract does not have a set-aside designation, indicating open competition. As a major supplier of medical products to federal agencies, AmerisourceBergen plays a critical role in supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries through its extensive pharmaceutical distribution capabilities.

Generated 5/7/25, 9:58 AM